Homozygous Familial Hypercholesterolaemia (HoFH)

DBCOND0135612Blood CholesterolGenetic Diseases, Inborn

Homozygous Familial Hypercholesterolaemia (HoFH) is the indication for 10 drugs in DrugBank. It is covered by 20 curated, structured indications.

Also known as
Homozygous Familial Hypercholesterolemia · Familial Hypercholesterolemia - Homozygous · Homozygous Familial Hypercholesterolemia (HoFH) · Homozygous Familial Hypercholesterolemia HoFH · HoFH
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000746765ICD-10E78.00SNOMED CT238078005MedDRA10017342UMLSC0342881

What you can answer from here — as of October 23, 2026

10Indicated drugsWith each drug's targets and mechanism
Listed above
20Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
58Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Homozygous Familial Hypercholesterolaemia (HoFH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In